December 23, 2024
For almost two decades, antidepressants have carried boxed warnings linking the medications to an increased risk for suicidal thoughts and behaviors in young people. Paradoxically, and for almost as long, evidence suggests these warnings may have led to fewer depression diagnoses, reduced prescriptions, and, ultimately, higher suicide rates.
With mounting evidence of these negative unintended consequences, some clinicians and researchers are urging the US Food and Drug Administration (FDA) to consider revising — or even eliminating — boxed warnings on these medications.
Read more here at Medscape Medical News.